These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19088508)

  • 1. B-type natriuretic peptide in end-stage renal disease: a neurohormone rather than a volume status monitor.
    Maeder MT; Kaye DM
    South Med J; 2008 Nov; 101(11):1081-2. PubMed ID: 19088508
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain natriuretic peptide (BNP): a new risk marker in hemodialysis patients?
    Jorge S; Lopes JA; Neves F; Gomes da Costa A; Prata MM
    South Med J; 2008 Nov; 101(11):1083. PubMed ID: 19088509
    [No Abstract]   [Full Text] [Related]  

  • 3. Understanding cardiac biomarkers in end-stage kidney disease: Frequently asked questions and the promise of clinical application.
    Roberts MA; Hedley AJ; Ierino FL
    Nephrology (Carlton); 2011 Mar; 16(3):251-60. PubMed ID: 21342319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of B-type natriuretic peptide to assess volume status in dialysis patients.
    Codognotto M; Piccoli A
    Am Heart J; 2007 Nov; 154(5):e31. PubMed ID: 17967574
    [No Abstract]   [Full Text] [Related]  

  • 5. Is N-terminal probrain-type natriuretic peptide a clinically useful biomarker of volume overload in peritoneal dialysis patients?
    Papakrivopoulou E; Lillywhite S; Davenport A
    Nephrol Dial Transplant; 2012 Jan; 27(1):396-401. PubMed ID: 21765049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease.
    Sheen V; Bhalla V; Tulua-Tata A; Bhalla MA; Weiss D; Chiu A; Abdeen O; Mullaney S; Maisel A
    Am Heart J; 2007 Feb; 153(2):244.e1-5. PubMed ID: 17239684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic, prognostic, and therapeutic implications of brain natriuretic peptide in dialysis and nondialysis-dependent chronic renal failure.
    Mark PB; Petrie CJ; Jardine AG
    Semin Dial; 2007; 20(1):40-9. PubMed ID: 17244121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T.
    Sommerer C; Giannitsis E; Schwenger V; Zeier M
    Nephron Clin Pract; 2007; 107(3):c77-81. PubMed ID: 17890874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoterminal B-type natriuretic peptide (NT-proBNP) in end-stage renal failure patients on regular hemodialysis: does it have diagnostic and prognostic implications?
    Pimenta J; Sampaio F; Martins P; Carvalho B; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    Nephron Clin Pract; 2009; 111(3):c182-8. PubMed ID: 19194108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident haemodialysis patients.
    Chazot C; Vo-Van C; Zaoui E; Vanel T; Hurot JM; Lorriaux C; Mayor B; Deleaval P; Jean G
    Nephrol Dial Transplant; 2011 Aug; 26(8):2630-4. PubMed ID: 21273234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide levels and cardiovascular risk in patients with diastolic dysfunction on chronic haemodialysis: cross-sectional and observational studies.
    Takase H; Dohi Y; Toriyama T; Okado T; Tanaka S; Shinbo H; Kimura G
    Nephrol Dial Transplant; 2011 Feb; 26(2):683-90. PubMed ID: 20624772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal dysfunction, hemodialysis, and the NT-proBNP/BNP ratio.
    Jacobs LH; Mingels AM; Wodzig WK; van Dieijen-Visser MP; Kooman JP
    Am J Clin Pathol; 2010 Sep; 134(3):516-7; author reply 517. PubMed ID: 20716809
    [No Abstract]   [Full Text] [Related]  

  • 14. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate.
    Scheven L; de Jong PE; Hillege HL; Lambers Heerspink HJ; van Pelt LJ; Kootstra JE; Bakker SJ; Gansevoort RT;
    Eur Heart J; 2012 Sep; 33(18):2272-81. PubMed ID: 22740385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of intradialytic exercise on arterial compliance and B-type natriuretic peptide levels in hemodialysis patients.
    Toussaint ND; Polkinghorne KR; Kerr PG
    Hemodial Int; 2008 Apr; 12(2):254-63. PubMed ID: 18394060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of dialysis type on biomarkers for cardiovascular diseases.
    Sahinarslan A; Güz G; Mutluay R; Okyay K; Demirtaş C; Paşaoğlu H; Yalçın R
    Turk Kardiyol Dern Ars; 2011 Sep; 39(6):456-62. PubMed ID: 21918314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of B-type natriuretic peptide is a sensitive marker of left ventricular diastolic dysfunction in patients with maintenance haemodialysis.
    Liu H; Zhang YZ; Gao M; Liu BC
    Biomarkers; 2010 Sep; 15(6):533-7. PubMed ID: 20536328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of cardiac biomarkers in end-stage renal disease.
    Wang AY; Lai KN
    J Am Soc Nephrol; 2008 Sep; 19(9):1643-52. PubMed ID: 18322158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are levels of brain natriuretic peptides useful to determine volume status in dialysis patients?
    Vukelic V; Peixoto AJ
    Semin Dial; 2011; 24(4):400-2. PubMed ID: 21851400
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma B-type natriuretic peptide in dialyzed patients: marker of cardiovascular disease or link to plasma refilling.
    De Mauri A; Bellomo G; Navino C; David P; Chiarinotti D; Capurro F; Brustia M; De Maria M; Ruva CE; Ciardi L; De Leo M
    J Nephrol; 2011; 24(4):507-14. PubMed ID: 21240867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.